查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555776

胰高血糖素輸送設備市場，按類型、按配銷通路、按應用、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Glucagon Delivery Devices Market, By Type, By Distribution Channel, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年胰高血糖素輸送設備市場規模為21.5042億美元，2024年至2032年複合年成長率為8.72%。

胰高血糖素傳輸設備市場-市場動態

糖尿病盛行率上升推動了對胰高血糖素輸送設備的需求

糖尿病盛行率的激增顯著增加了對胰高血糖素輸送設備的需求。據國際糖尿病聯盟稱，全球有超過 4.5 億人患有糖尿病，因此迫切需要胰高血糖素等有效的緊急治療方法。例如，美國糖尿病協會報告稱，嚴重的低血糖發作需要給予胰高血糖素，影響很大一部分糖尿病患者，特別是第 1 型糖尿病患者。作為回應，禮來公司等公司正在擴大其產品線並改進設備技術，以滿足不斷成長的需求。此外，美國和歐洲的健康計劃強調更好的糖尿病管理解決方案，進一步加速先進胰高血糖素輸送設備的採用。這些努力凸顯了胰高血糖素設備在管理糖尿病相關緊急情況和確保更好的患者治療結果方面的關鍵作用。

胰高血糖素傳輸設備市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.72% 左右的複合年成長率成長

根據類型細分，自動注射器預計將在 2023 年顯示最大的市場佔有率

從配銷通路細分來看，零售藥局是2023年的主導類型

按應用細分，2023年應急包為主導類型

按地區分類，北美是 2023 年的主要收入來源

胰高血糖素輸送設備市場細分分析：

全球胰高血糖素輸送設備市場根據類型、配銷通路、應用、最終用戶和地區進行細分。

市場依類型分為四大類：預充式注射器、自動注射器、鼻噴劑和無針注射器。自動注射器因其易於使用且在緊急情況下有效而具有最高優先級。預裝注射器緊隨其後，因其方便而受到重視。鼻噴劑越來越受歡迎，而無針注射器雖小眾，但正在不斷成長。

根據配銷通路，市場分為三類：醫院藥房、零售藥房和線上藥房。零售藥局因其廣泛的可及性和患者的熟悉度而處於領先地位。醫院藥房緊隨其後，滿足醫院內的需求和緊急情況。網路藥局不斷發展，為家庭使用提供了便利和廣泛的選擇。

胰高血糖素傳輸設備市場 - 地理洞察

胰高血糖素輸送設備市場呈現不同的區域動態，其中北美由於糖尿病盛行率高和醫療基礎設施先進而處於領先地位。在美國，超過 3000 萬人患有糖尿病，這推動了對有效胰高血糖素輸送解決方案的需求。美國糖尿病協會的舉措，例如推廣更好的管理工具，進一步促進了市場成長。歐洲緊隨其後，德國和英國等國家投資先進的糖尿病照護技術。德國最近對糖尿病研究和開發的資助凸顯了該地區對改進胰高血糖素輸送設備的承諾。由於糖尿病發病率上升和醫療保健投資增加，亞太地區，特別是中國和印度，正在迅速崛起。例如，中國的國家衛生計畫的重點是加強糖尿病管理基礎設施，這正在擴大胰高血糖素輸送設備的市場。這些區域性努力反映出全球日益關注改善糖尿病照護和緊急治療選擇。

胰高血糖素輸送設備市場-競爭格局：

胰高血糖素輸送設備市場競爭激烈，禮來公司、諾和諾德和賽諾菲等主要參與者處於領先地位。例如，禮來公司（Eli Lilly）一直透過策略合作擴大其市場佔有率； 2022年，該公司與 Dexcom 合作，將胰高血糖素輸送與連續血糖監測系統整合，以提高糖尿病管理的有效性。諾和諾德也透過在 2021 年收購糖尿病科技公司 Glooko 來鞏固其地位，旨在利用 Glooko 的數位健康解決方案來補充其胰高血糖素輸送設備。主要競爭對手賽諾菲一直積極進行研發，專注於提高胰高血糖素自動注射器的易用性和可靠性。這些策略性舉措和合作反映了參與者對推動胰高血糖素輸送技術和滿足日益成長的糖尿病護理需求的承諾。

最新進展：

2019 年 9 月，Xeris Pharmaceuticals 的 G-Voke 獲得 FDA 批准，這是首款即用型、室溫穩定的液體胰高血糖素，用於治療 2 歲及以上糖尿病患者的嚴重低血糖。 G-Voke 提供了比傳統胰高血糖素急救包更簡單、更快捷的替代方案。

目錄

第 1 章：胰高血糖素輸送設備市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依類型分類的胰高血糖素輸送設備市場片段
    • 依配銷通路分類的胰高血糖素輸送設備市場片段
    • 胰高血糖素輸送設備市場片段（依應用）
    • 最終用戶的胰高血糖素傳輸設備市場片段
    • 按國家/地區分類的胰高血糖素輸送設備市場片段
    • 按地區分類的胰高血糖素輸送設備市場片段
  • 競爭洞察

第 3 章：胰高血糖素輸送設備主要市場趨勢

  • 胰高血糖素輸送設備市場促進因素
    • 市場促進因素的影響分析
  • 胰高血糖素傳輸設備市場限制
    • 市場限制影響分析
  • 胰高血糖素輸送裝置的市場機會
  • 胰高血糖素輸送設備市場未來趨勢

第 4 章：胰高血糖素輸送裝置產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：胰高血糖素輸送設備市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：胰高血糖素輸送設備市場格局

  • 2023 年胰高血糖素輸送設備市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：胰高血糖素輸送設備市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 預充式注射器
    • 自動注射器
    • 鼻噴劑
    • 無針注射器

第 8 章：胰高血糖素輸送設備市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局

第 9 章：胰高血糖素輸送設備市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 緊急包
    • 糖尿病患者
    • 診斷測試

第 10 章：胰高血糖素輸送設備市場 - 按下最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 家庭護理設置
    • 緊急醫療服務

第 11 章：胰高血糖素輸送設備市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 胰高血糖素輸送裝置北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按配銷通路）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲胰高血糖素傳輸裝置主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按配銷通路）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區胰高血糖素傳輸設備主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模和預測（按配銷通路）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲胰高血糖素傳輸裝置主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 胰高血糖素輸送裝置中東和非洲的主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 胰高血糖素輸送設備產業

  • 競爭儀表板
  • 公司簡介
    • Amphastar Pharmaceuticals, Inc.
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Eli Lilly and Company
    • Fresenius Kabi AG
    • GlaxoSmithKline plc
    • Kaleo, Inc.
    • Medtronic plc
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sandoz International GmbH
    • Sanofi SA
    • Wockhardt Limited
    • Xeris Pharmaceuticals, Inc.
    • Ypsomed AG
    • Zealand Pharma A/S
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3731

REPORT HIGHLIGHT

Glucagon Delivery Devices Market size was valued at USD 2,150.42 million in 2023, expanding at a CAGR of 8.72% from 2024 to 2032.

The Glucagon Delivery Devices Market is experiencing significant growth due to the increasing prevalence of diabetes and the rising demand for efficient glucose management solutions. Glucagon delivery devices are used to administer glucagon, a hormone that raises blood glucose levels, in emergencies such as severe hypoglycemia. The market is bolstered by technological advancements, including the development of more user-friendly and precise delivery systems. For instance, a recent survey indicated that over 70% of endocrinologists prefer devices with automated features to ensure accurate dosing. However, the market faces challenges such as the high cost of advanced devices and the need for patient education on proper usage. Opportunities exist to expand personalized and connected glucagon delivery systems that integrate with digital health platforms. For example, the integration of smart technology into glucagon delivery devices is expected to enhance patient compliance and overall diabetes management.

Glucagon Delivery Devices Market- Market Dynamics

Rising Diabetes Prevalence Drives Demand for Glucagon Delivery Devices

The surge in diabetes prevalence is significantly boosting the demand for glucagon-delivery devices. According to the International Diabetes Federation, over 450 million people worldwide are living with diabetes, creating a substantial need for effective emergency treatments like glucagon. For instance, the American Diabetes Association reports that severe hypoglycemic episodes, which require glucagon administration, affect a significant portion of diabetic patients, particularly those with type 1 diabetes. In response, companies such as Eli Lilly are expanding their product lines and improving device technology to meet the growing demand. Additionally, health initiatives in the U.S. and Europe are emphasizing better diabetes management solutions, further accelerating the adoption of advanced glucagon delivery devices. These efforts highlight the critical role of glucagon devices in managing diabetes-related emergencies and ensuring better patient outcomes.

Glucagon Delivery Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.72% over the forecast period (2024-2032)

Based on Type segmentation, Auto-Injectors were predicted to show maximum market share in the year 2023

Based on Distribution Channel segmentation, Retail Pharmacies were the leading type in 2023

Based on Application segmentation, Emergency Kits was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Glucagon Delivery Devices Market- Segmentation Analysis:

The Global Glucagon Delivery Devices Market is segmented on the basis of Type, Distribution Channel, Application, End-User, and Region.

The market is divided into four categories based on Type: Prefilled Syringes, Auto-Injectors, Nasal Sprays, and Needle-Free Injectors. Auto-injectors hold the highest priority due to their ease of use and effectiveness in emergencies. Prefilled Syringes follow, valued for their convenience. Nasal Sprays are gaining traction, while Needle-Free Injectors are niche but growing.

The market is divided into three categories based on Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Retail Pharmacies lead due to their widespread accessibility and patient familiarity. Hospital Pharmacies follow, catering to in-hospital needs and emergency situations. Online Pharmacies are growing, offering convenience and a broad selection for home use.

Glucagon Delivery Devices Market- Geographical Insights

The Glucagon Delivery Devices Market shows varied regional dynamics, with North America leading due to high diabetes prevalence and advanced healthcare infrastructure. In the U.S., over 30 million people have diabetes, driving demand for effective glucagon delivery solutions. The American Diabetes Association's initiatives, such as the promotion of better management tools, further bolster market growth. Europe follows, with countries like Germany and the U.K. investing in advanced diabetes care technologies. Germany's recent funding for diabetes research and development highlights the region's commitment to improving glucagon delivery devices. The Asia-Pacific region, notably China and India, is emerging rapidly due to increasing diabetes rates and rising healthcare investments. For instance, China's national health initiatives are focusing on enhancing diabetes management infrastructure, which is expanding the market for glucagon delivery devices. These regional efforts reflect a growing global focus on improving diabetes care and emergency treatment options.

Glucagon Delivery Devices Market- Competitive Landscape:

The Glucagon Delivery Devices Market is highly competitive, with major players such as Eli Lilly and Company, Novo Nordisk, and Sanofi at the forefront. Eli Lilly, for example, has been expanding its market presence through strategic collaborations; in 2022, the company partnered with Dexcom to integrate glucagon delivery with continuous glucose monitoring systems, enhancing the effectiveness of diabetes management. Novo Nordisk has also strengthened its position by acquiring the diabetes technology company, Glooko, in 2021, aiming to leverage Glooko's digital health solutions to complement its glucagon delivery devices. Sanofi, a key competitor, has been active in research and development, focusing on improving the ease of use and reliability of its glucagon auto-injectors. These strategic initiatives and collaborations reflect the players' commitment to advancing glucagon delivery technologies and meeting the growing demands of diabetes care.

Recent Developments:

In September 2019, Xeris Pharmaceuticals received FDA approval for G-Voke, the first ready-to-use, room-temperature stable liquid glucagon for severe hypoglycemia in diabetes patients aged 2 and above. G-Voke offers a simpler, faster alternative to traditional glucagon emergency kits.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GLUCAGON DELIVERY DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amphastar Pharmaceuticals, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Kaleo, Inc.
  • Medtronic plc
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Wockhardt Limited
  • Xeris Pharmaceuticals, Inc.
  • Ypsomed AG
  • Zealand Pharma A/S
  • Others

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Prefilled Syringes
  • Auto-Injectors
  • Nasal Sprays
  • Needle-Free Injectors

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Emergency Kits
  • Diabetic Patients
  • Diagnostic Testing

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Homecare Settings
  • Emergency Medical Services

GLOBAL GLUCAGON DELIVERY DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Glucagon Delivery Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Glucagon Delivery Devices Market Snippet by Type
    • 2.1.2. Glucagon Delivery Devices Market Snippet by Distribution Channel
    • 2.1.3. Glucagon Delivery Devices Market Snippet by Application
    • 2.1.4. Glucagon Delivery Devices Market Snippet by End-User
    • 2.1.5. Glucagon Delivery Devices Market Snippet by Country
    • 2.1.6. Glucagon Delivery Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Glucagon Delivery Devices Key Market Trends

  • 3.1. Glucagon Delivery Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Glucagon Delivery Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Glucagon Delivery Devices Market Opportunities
  • 3.4. Glucagon Delivery Devices Market Future Trends

4. Glucagon Delivery Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Glucagon Delivery Devices Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Glucagon Delivery Devices Market Landscape

  • 6.1. Glucagon Delivery Devices Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Glucagon Delivery Devices Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Prefilled Syringes
    • 7.1.3. Auto-Injectors
    • 7.1.4. Nasal Sprays
    • 7.1.5. Needle-Free Injectors

8. Glucagon Delivery Devices Market - By Distribution Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2023 & 2032 (%)
    • 8.1.2. Hospital Pharmacies
    • 8.1.3. Retail Pharmacies
    • 8.1.4. Online Pharmacies

9. Glucagon Delivery Devices Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Emergency Kits
    • 9.1.3. Diabetic Patients
    • 9.1.4. Diagnostic Testing

10. Glucagon Delivery Devices Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Homecare Settings
    • 10.1.5. Emergency Medical Services

11. Glucagon Delivery Devices Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Glucagon Delivery Devices Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Glucagon Delivery Devices Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Glucagon Delivery Devices Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Glucagon Delivery Devices Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Glucagon Delivery Devices Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Glucagon Delivery Devices Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Amphastar Pharmaceuticals, Inc.
    • 12.2.2. Baxter International Inc.
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Eli Lilly and Company
    • 12.2.5. Fresenius Kabi AG
    • 12.2.6. GlaxoSmithKline plc
    • 12.2.7. Kaleo, Inc.
    • 12.2.8. Medtronic plc
    • 12.2.9. Novo Nordisk A/S
    • 12.2.10. Pfizer Inc.
    • 12.2.11. Sandoz International GmbH
    • 12.2.12. Sanofi S.A.
    • 12.2.13. Wockhardt Limited
    • 12.2.14. Xeris Pharmaceuticals, Inc.
    • 12.2.15. Ypsomed AG
    • 12.2.16. Zealand Pharma A/S
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us